• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难溶性研究分子 ODM-106 的纳米混悬剂:研磨珠直径和稳定剂浓度的影响。

Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.

机构信息

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Viikinkaari 5 E, 00014 Helsinki, Finland; Orion Pharma R&D, Global Pharmaceutical Research, P.O. Box 65, 02101 Espoo, Finland.

Drug Research Program, Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, P.O. Box 56, Viikinkaari 5 E, 00014 Helsinki, Finland.

出版信息

Int J Pharm. 2020 Sep 25;587:119636. doi: 10.1016/j.ijpharm.2020.119636. Epub 2020 Jul 11.

DOI:10.1016/j.ijpharm.2020.119636
PMID:32659405
Abstract

Aqueous solubility of a drug substance is an important attribute affecting oral bioavailability. Nanonization, particle size reduction to submicron level, is an elegant approach to improve drug solubility and dissolution by increasing the surface energy, which in turn necessitates the use of stabilizers. The purpose of this study was to develop a nanosuspension of a practically water-insoluble investigational molecule by nanomilling approach using wet media milling. A variety of polymeric and surface active excipients were tested for their wettability. A combination of hydroxypropyl methylcellulose and sodium lauryl sulfate (SLS) were selected as stabilizers on the bases of compatibility studies and efficient wettability behaviour in contact angle measurements (≈80˚). A factorial design set-up was used to study the effect of milling bead diameter and stabilizer concentration on the efficiency of particle size reduction. Nanonization outcome was different when milling beads of 0.5 mm and 1 mm diameter were used at different concentrations of the stabilizers, which demonstrated the complex nature of the whole system. Storage of the nanosuspensions under different temperature conditions resulted only in minor changes of the particle size fractions.

摘要

药物的水溶解度是影响口服生物利用度的一个重要属性。纳米化,即将粒径减小到亚微米级,是一种通过增加表面能来提高药物溶解度和溶解速率的优雅方法,这反过来又需要使用稳定剂。本研究的目的是通过使用湿介质研磨的纳米研磨方法开发一种实用上不溶于水的研究分子的纳米悬浮液。对各种聚合物和表面活性剂辅料进行了润湿性测试。根据相容性研究和接触角测量(≈80˚)中有效润湿性行为,选择羟丙基甲基纤维素和十二烷基硫酸钠(SLS)的组合作为稳定剂。使用因子设计设置来研究研磨珠直径和稳定剂浓度对粒径减小效率的影响。当以不同浓度的稳定剂使用 0.5 和 1 毫米直径的研磨珠时,纳米化结果不同,这表明整个系统的复杂性。在不同温度条件下储存纳米悬浮液仅导致粒径分数的微小变化。

相似文献

1
Nanosuspensions of a poorly soluble investigational molecule ODM-106: Impact of milling bead diameter and stabilizer concentration.难溶性研究分子 ODM-106 的纳米混悬剂:研磨珠直径和稳定剂浓度的影响。
Int J Pharm. 2020 Sep 25;587:119636. doi: 10.1016/j.ijpharm.2020.119636. Epub 2020 Jul 11.
2
A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.基于质量源于设计的硝苯地平纳米混悬剂的研制:考察制剂变量、湿磨工艺参数和辅料变异性对药物产品质量属性的相对影响。
Drug Dev Ind Pharm. 2018 Dec;44(12):1942-1952. doi: 10.1080/03639045.2018.1503296. Epub 2018 Oct 12.
3
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.咪康唑纳米混悬剂:制剂变量对粒径减小和物理稳定性的影响。
Int J Pharm. 2010 Aug 30;396(1-2):210-8. doi: 10.1016/j.ijpharm.2010.06.020. Epub 2010 Jun 19.
4
Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.食物蛋白作为新型纳米混悬剂稳定剂用于难溶性药物。
Int J Pharm. 2013 Jan 30;441(1-2):269-78. doi: 10.1016/j.ijpharm.2012.11.033. Epub 2012 Nov 27.
5
Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions.湿磨法制备依托度酸纳米混悬剂的处方和工艺参数研究。
Pharm Res. 2020 May 31;37(6):111. doi: 10.1007/s11095-020-02815-x.
6
A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.用于制备微/纳米混悬液的自上而下和自下而上方法的比较研究。
Int J Pharm. 2009 Oct 1;380(1-2):216-22. doi: 10.1016/j.ijpharm.2009.07.005. Epub 2009 Jul 22.
7
Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.难溶性药物的纳米混悬剂:湿磨法制备与开发。
Int J Pharm. 2011 Jun 15;411(1-2):215-22. doi: 10.1016/j.ijpharm.2011.03.050. Epub 2011 Mar 31.
8
Fabrication of multicomponent amorphous bufadienolides nanosuspension with wet milling improves dissolution and stability.湿磨法制备多组分无定形蟾蜍甾烯类纳米混悬剂可提高溶解度和稳定性。
Artif Cells Nanomed Biotechnol. 2018 Nov;46(7):1513-1522. doi: 10.1080/21691401.2017.1375938. Epub 2017 Sep 14.
9
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.用于提高难溶性药物生物利用度的纳米混悬剂和抑制晶体生长的稳定剂筛选。
Int J Pharm. 2011 May 16;409(1-2):260-8. doi: 10.1016/j.ijpharm.2011.02.051. Epub 2011 Mar 1.
10
Is the amorphous fraction of a dried nanosuspension caused by milling or by drying? A case study with Naproxen and Cinnarizine.干燥纳米混悬剂的无定形部分是由研磨还是干燥引起的?萘普生和肉桂嗪的案例研究。
Eur J Pharm Biopharm. 2012 Aug;81(3):650-6. doi: 10.1016/j.ejpb.2012.04.020. Epub 2012 May 2.

引用本文的文献

1
Nanoparticle-Based Dry Powder Inhaler Containing Ciprofloxacin for Enhanced Targeted Antibacterial Therapy.含环丙沙星的纳米颗粒干粉吸入器用于增强靶向抗菌治疗
Pharmaceutics. 2025 Apr 7;17(4):486. doi: 10.3390/pharmaceutics17040486.
2
Characterisation and Stabilisation Mechanisms of Azelaic Acid Nanosuspensions: Insights from a Dual Stabiliser System.壬二酸纳米混悬液的表征及稳定机制:来自双稳定剂系统的见解
Pharmaceutics. 2025 Mar 29;17(4):439. doi: 10.3390/pharmaceutics17040439.
3
Key Challenges, Influencing Factors, and Future Perspectives of Nanosuspensions in Enhancing Brain Drug Delivery.
纳米混悬剂增强脑内药物递送的关键挑战、影响因素和未来展望。
Curr Pharm Des. 2024;30(32):2524-2537. doi: 10.2174/0113816128317347240625105501.
4
Design of High-Payload Ascorbyl Palmitate Nanosuspensions for Enhanced Skin Delivery.用于增强皮肤递送的高负载量棕榈酸维生素C纳米混悬液的设计
Pharmaceutics. 2024 Jan 25;16(2):171. doi: 10.3390/pharmaceutics16020171.
5
Recent advances in targeting the "undruggable" proteins: from drug discovery to clinical trials.靶向“不可成药”蛋白的最新进展:从药物发现到临床试验。
Signal Transduct Target Ther. 2023 Sep 6;8(1):335. doi: 10.1038/s41392-023-01589-z.
6
Systematic Screening Study for the Selection of Proper Stabilizers to Produce Physically Stable Canagliflozin Nanosuspension by Wet Milling Method.通过湿磨法筛选合适稳定剂以制备物理稳定的卡格列净纳米混悬液的系统研究
Bioengineering (Basel). 2023 Aug 4;10(8):927. doi: 10.3390/bioengineering10080927.
7
Transformation of Ritonavir Nanocrystal Suspensions into a Redispersible Drug Product via Vacuum Drum Drying.真空滚筒干燥法将利托那韦纳米晶体混悬液转化为再分散药物产品。
AAPS PharmSciTech. 2022 May 9;23(5):137. doi: 10.1208/s12249-022-02283-z.
8
Naringenin nanocrystals for improving anti-rheumatoid arthritis activity.用于改善抗类风湿性关节炎活性的柚皮素纳米晶体。
Asian J Pharm Sci. 2021 Nov;16(6):816-825. doi: 10.1016/j.ajps.2021.09.001. Epub 2021 Sep 16.